|
Overview
The workshop program will cover the latest
advances in the application of MR to cancer research, and will feature invited
presentations by scientists from the field of clinical oncology and radiology,
as well as from experimental radiology and cancer imaging. In addition to
invited scientific presentations, the program will include an educational
lecture, presentations of proffered papers, poster sessions, and the Negendank
Memorial Lecture on a special topic of clinical relevance.
The goals of the workshop are to present results from cutting-edge experimental
imaging and to explore and develop translational research for clinical
applications. This is the first time the MR of Cancer Workshop will be
held in the Eastern United States since the inception of this workshop in
Baltimore in 1996.
|
Educational Objectives
Upon
completion of this workshop, attendees should be able to:
|
|
1.
describe the
use of in vivo MRI and MRS methods in clinical and experimental oncology
;
2. evaluate the role of in vivo NMR methods in clinical trials;
3. interpret information provided by in vivo NMR methods in the
assessment of cancer treatment response and/or systemic toxicity;
4. predict the nature of future NMR methods used in experimental and
clinical imaging of cancer;
5. describe recent advances in molecular imaging of cancer;
6. define advances in targeted contrast agents in molecular cancer
imaging; and
7. explain the potential role of metabolomics in cancer diagnosis and
treatment.
|
Audience Description
|
This workshop is designed for
• Basic researchers in laboratories using in vivo MRS/MRI or other MR
methods in drug development, cancer research, molecular imaging, at the
level of faculty, post-doctoral fellows and graduate students;
• Clinical investigators and clinicians in radiology, oncology, or
pharmacology; and
• Industry scientists employing MR imaging and spectroscopy in the
pharmaceutical industry or contrast agent / molecular imaging companies.
Members of the audience would have particular interests in methodological
development of in vivo MRS and MRI, including applications of MRS and MRI to
basic cancer research, clinical translation of MRS and MRI, applications to
drug development and contrast agent development
|